April 2023

HEZBOLLAH CHIEF WELCOMES IRANIAN FOREIGN MINISTER

Hezbollah Secretary General, Sayyed Hassan Nasrallah, on Friday welcomed Iranian Foreign Minister Dr. Hossein Amir Abdollahian, who visited him with an accompanying delegation, in the presence of Iranian Ambassador to Beirut, Mojtaba Amani.The meeting…

Read More

GEAGEA MEETS MAKHZOUMI OVER LATEST DEVELOPMENTS

“Lebanese Forces” party leader, Samir Geagea, on Friday welcomed MP Fouad Makhzoumi, with whom he discussed the most recent developments vis-a-vis the presidential election dossier.The meeting also focused on the outcome of the Lebanese parliamentary …

Read More

GCC chief meets Azerbaijan Amb. on ties

GCC General Secretary Jasem Al-Budaiwi and Azerbaijan Ambassador to Saudi Arabia Shahin Abdullayev discussed on Friday bilateral relations and the GCC-Azerbaijan economic forum, after the successful edition of 2017.In a statement, the GCC General Secre…

Read More

Bahraini Ambassador holds meetings in Montenegro

Ambassador of the Kingdom of Bahrain to Montenegro, residing in Ankara, Dr. Ebrahim Yusuf Al-Abdulla, met here today the President of the Parliament of Montenegro, Danijela Ðurovic, on the sidelines of his visit to the country to present his credential…

Read More

Sharjah FC crowned champion of President’s Cup

Sharjah FC was crowned champion of the 2022 -2023 UAE President’s Cup. The team clinched the trophy, the 10th in its history, for the second consecutive time after an exciting final with Al-Ain at the Mohamed bin Zayed Stadium in Abu Dhabi today Friday…

Read More

EQUITY ALERT: ROSEN, A TRUSTED AND LEADING LAW FIRM, Encourages Edgio, Inc. f/k/a Limelight Networks, Inc. Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action – EGIO, LLNW

NEW YORK, April 27, 2023 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of securities of Edgio, Inc. f/k/a Limelight Networks, Inc. (NASDAQ: EGIO, LLNW) between February 11, 2021 and March 12, 2023, both dates inclusive (the “Class Period”). A […]

Read More

ROSEN, A TRUSTED AND LEADING LAW FIRM, Encourages Credit Suisse Group AG Investors with Losses in Excess of $1 Million to Secure Counsel Before Important May 8 Deadline in Securities Class Action – CS

NEW YORK, April 27, 2023 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Credit Suisse Group AG (NYSE: CS) between February 18, 2021 and March 20, 2023, both dates inclusive (the “Class Period”), of the pendency of a securities class action lawsuit. The Class Period was […]

Read More

ROSEN, A GLOBAL AND LEADING LAW FIRM, Encourages DISH Network Corporation Investors to Secure Counsel Before Important Deadline in Securities Class Action – DISH

NEW YORK, April 27, 2023 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of DISH Network Corporation (NASDAQ: DISH) between February 22, 2021 and February 27, 2023, both dates inclusive (the “Class Period”), of the important May 22, 2023 lead plaintiff deadline. SO WHAT: If you purchased DISH securities […]

Read More

ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Vertex Energy, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – VTNR

NEW YORK, April 27, 2023 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of securities of Vertex Energy, Inc. (NASDAQ: VTNR) between April 1, 2022 and August 8, 2022, both dates inclusive (the “Class Period”). A class action […]

Read More

BioMed X Launches XSeed Labs in the US with Boehringer Ingelheim – a New Model for Building an External Innovation Ecosystem on an Industry Campus

RIDGEFIELD, CT / ACCESSWIRE / April 27, 2023 / BioMed X announced today the expansion of its collaboration with Boehringer Ingelheim with the launch of a new model for biomedical research: XSeed Labs. The first research project of the new lab will focus on fibrotic disease processes, a key focus area of Boehringer Ingelheim. It will aim […]

Read More